Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Nuvilex - 22 Year Stock Price History | PMCB

Historical daily share price chart and data for Nuvilex since 2003 adjusted for splits and dividends. The latest closing stock price for Nuvilex as of May 20, 2025 is 1.04.
  • The all-time high Nuvilex stock closing price was 1080.05 on May 13, 2004.
  • The Nuvilex 52-week high stock price is 2.42, which is 132.7% above the current share price.
  • The Nuvilex 52-week low stock price is 1.00, which is 3.8% below the current share price.
  • The average Nuvilex stock price for the last 52 weeks is 1.69.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Nuvilex Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 1.4537 1.6401 1.8100 1.0300 1.0400 -33.76%
2024 1.9734 2.1850 2.5200 1.4700 1.5700 -27.31%
2023 2.6618 2.9300 3.1800 2.0100 2.1600 -26.28%
2022 2.4524 2.7700 3.0700 1.9100 2.9300 17.20%
2021 14.8461 11.2506 50.4025 2.2800 2.5000 -75.13%
2020 34.9106 61.2031 85.3543 6.3003 10.0505 -83.46%
2019 60.8913 58.7129 93.0047 48.0024 60.7530 9.46%
2018 86.0040 91.5046 147.4570 55.5028 55.5028 -33.69%
2017 112.9108 214.4960 214.4960 49.5025 83.7042 -62.53%
2016 91.1816 84.7542 234.7620 42.7521 223.3610 223.84%
2015 176.8013 288.0140 325.5160 68.9735 68.9735 -74.46%
2014 380.8679 171.7590 765.0380 171.7590 270.0130 76.47%
2013 158.1187 55.5028 308.8660 39.0020 153.0080 176.42%
2012 69.7818 70.5035 106.5050 36.0018 55.3528 -18.90%
2011 65.8985 26.2513 105.0050 19.5010 68.2534 264.00%
2010 19.9340 39.0020 45.0023 9.7505 18.7509 -55.36%
2009 62.3722 52.5026 139.5070 30.1515 42.0021 -26.32%
2008 175.2882 315.0160 345.0170 45.0023 57.0029 -82.65%
2007 468.9670 262.5130 742.5370 247.5120 328.5160 28.82%
2006 381.6177 382.5190 742.5370 240.0120 255.0130 -34.62%
2005 478.9418 630.0310 780.0390 255.0130 390.0200 -38.10%
2004 727.7065 675.0340 1080.0500 375.0190 630.0310 5.00%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.007B $0.000B
PharmaCyte Biotech, Inc. is a clinical stage biotechnology company. It is focused on developing and preparing to commercialize treatments for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box(R). The Company's patented technology is used in the treatment of several types of cancer, including advanced, inoperable pancreatic cancer and diabetes. PharmaCyte Biotech, Inc., formerly known as Nuvilex, Inc., is based in United States.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $87.021B 32.64
Zoetis (ZTS) United States $72.987B 27.23
Daiichi Sankyo, - (DSNKY) Japan $49.540B 25.20
Takeda Pharmaceutical (TAK) Japan $45.278B 9.01
Sandoz Group AG (SDZNY) Switzerland $20.747B 0.00
Summit Therapeutics (SMMT) United States $17.831B 0.00
Merck (MKKGY) Germany $16.820B 12.32
United Therapeutics (UTHR) United States $13.772B 12.18
Shionogi (SGIOY) Japan $13.084B 13.11
Neurocrine Biosciences (NBIX) United States $12.155B 41.63
IPSEN (IPSEY) France $9.731B 0.00
Orion OYJ (ORINY) Finland $8.979B 24.28
Corcept Therapeutics (CORT) United States $7.934B 64.50
Stevanato Group S.p.A (STVN) Italy $7.504B 45.89
Madrigal Pharmaceuticals (MDGL) United States $6.455B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.976B 0.00
Grifols, S.A (GRFS) Spain $5.500B 0.00
Ionis Pharmaceuticals (IONS) United States $5.416B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.040B 15.33
Soleno Therapeutics (SLNO) United States $3.809B 0.00
Catalyst Pharmaceuticals (CPRX) United States $3.004B 10.53
Crinetics Pharmaceuticals (CRNX) United States $2.898B 0.00
Hypermarcas (HYPMY) Brazil $2.755B 18.12
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.351B 12.71
BioCryst Pharmaceuticals (BCRX) United States $2.170B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.090B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.833B 0.00
Guardian Pharmacy Services (GRDN) United States $1.678B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.638B 0.00
Indivior (INDV) United States $1.610B 6.83
Evotec AG (EVO) Germany $1.410B 0.00
ARS Pharmaceuticals (SPRY) United States $1.401B 0.00
Dyne Therapeutics (DYN) United States $1.325B 0.00
Ocular Therapeutix (OCUL) United States $1.196B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.090B 21.81
Harrow (HROW) United States $1.038B 0.00
Ardelyx (ARDX) United States $0.971B 0.00
Collegium Pharmaceutical (COLL) United States $0.958B 5.17
Avadel Pharmaceuticals (AVDL) Ireland $0.905B 0.00
Enliven Therapeutics (ELVN) United States $0.827B 0.00
Cronos Group (CRON) Canada $0.798B 0.00
Xeris Biopharma Holdings (XERS) United States $0.762B 0.00
Akebia Therapeutics (AKBA) United States $0.735B 0.00
AleAnna (ANNA) United States $0.667B 0.00
KalVista Pharmaceuticals (KALV) United States $0.600B 0.00
Xencor (XNCR) United States $0.574B 0.00
Bioventus (BVS) United States $0.569B 14.44
USANA Health Sciences (USNA) United States $0.560B 12.17
Elite Pharmaceuticals (ELTP) United States $0.552B 0.00
Regulus Therapeutics (RGLS) United States $0.545B 0.00
Savara (SVRA) United States $0.541B 0.00
Relay Therapeutics (RLAY) United States $0.502B 0.00
Zevra Therapeutics (ZVRA) United States $0.487B 0.00
CytoDyn (CYDY) United States $0.481B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.478B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.470B 0.00
Altimmune (ALT) United States $0.446B 0.00
Siga Technologies (SIGA) United States $0.433B 9.05
Tourmaline Bio (TRML) United States $0.427B 0.00
Organogenesis (ORGO) United States $0.410B 0.00
Verve Therapeutics (VERV) United States $0.390B 0.00
Oruka Therapeutics (ORKA) United States $0.386B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.352B 9.52
Heron Therapeutics (HRTX) United States $0.293B 0.00
Nature's Sunshine Products (NATR) United States $0.273B 25.22
Aquestive Therapeutics (AQST) United States $0.243B 0.00
ProKidney (PROK) United States $0.237B 0.00
MediWound (MDWD) Israel $0.222B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.195B 0.00
Wellgistics Health (WGRX) United States $0.193B 0.00
OmniAb (OABI) United States $0.189B 0.00
Nanobiotix S.A (NBTX) France $0.186B 0.00
Avita Medical (RCEL) United States $0.178B 0.00
4D Molecular Therapeutics (FDMT) United States $0.176B 0.00
Esperion Therapeutics (ESPR) United States $0.171B 0.00
Liminatus Pharma (LIMN) $0.164B 0.00
Journey Medical (DERM) United States $0.156B 0.00
Profound Medical (PROF) Canada $0.150B 0.00
Korro Bio (KRRO) United States $0.148B 0.00
Aldeyra Therapeutics (ALDX) United States $0.145B 0.00
Aclaris Therapeutics (ACRS) United States $0.141B 0.00
Inhibikase Therapeutics (IKT) United States $0.139B 0.00
Protara Therapeutics (TARA) United States $0.132B 0.00
Nektar Therapeutics (NKTR) United States $0.129B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.127B 0.00
Larimar Therapeutics (LRMR) United States $0.125B 0.00
Lyell Immunopharma (LYEL) United States $0.122B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Achieve Life Sciences (ACHV) Canada $0.115B 0.00
VAXART, INC (VXRT) United States $0.114B 0.00
Lexeo Therapeutics (LXEO) United States $0.109B 0.00
Fractyl Health (GUTS) United States $0.104B 0.00
Cassava Sciences (SAVA) United States $0.100B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.099B 0.00
OptiNose (OPTN) United States $0.098B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.095B 0.00
Cardiol Therapeutics (CRDL) Canada $0.093B 0.00
Galectin Therapeutics (GALT) United States $0.084B 0.00
Dominari Holdings (DOMH) United States $0.082B 0.00
Champions Oncology (CSBR) United States $0.082B 13.45
Cumberland Pharmaceuticals (CPIX) United States $0.082B 60.56
Arch Biopartners (ACHFF) Canada $0.080B 0.00
Inotiv (NOTV) United States $0.077B 0.00
Pyxis Oncology (PYXS) United States $0.076B 0.00
Telomir Pharmaceuticals (TELO) United States $0.076B 0.00
ESSA Pharma (EPIX) Canada $0.075B 0.00
Unicycive Therapeutics (UNCY) United States $0.073B 0.00
Surrozen (SRZN) United States $0.069B 0.00
Assertio Holdings (ASRT) United States $0.068B 0.00
Metagenomi (MGX) United States $0.064B 0.00
Nutriband (NTRB) United States $0.064B 0.00
Vivani Medical (VANI) United States $0.063B 0.00
Context Therapeutics (CNTX) United States $0.063B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.060B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Gain Therapeutics (GANX) United States $0.058B 0.00
Prelude Therapeutics (PRLD) United States $0.052B 0.00
Mural Oncology (MURA) Ireland $0.048B 0.00
Century Therapeutics (IPSC) United States $0.048B 0.00
PMV Pharmaceuticals (PMVP) United States $0.045B 0.00
Karyopharm Therapeutics (KPTI) United States $0.044B 0.00
Avalo Therapeutics (AVTX) United States $0.043B 0.00
NRx Pharmaceuticals (NRXP) United States $0.042B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.042B 0.00
Iterum Therapeutics (ITRM) Ireland $0.040B 0.00
ElectroCore (ECOR) United States $0.039B 0.00
Acrivon Therapeutics (ACRV) United States $0.037B 0.00
Rafael Holdings (RFL) United States $0.034B 0.00
SCYNEXIS (SCYX) United States $0.032B 0.00
FibroGen (FGEN) United States $0.032B 0.00
PolyPid (PYPD) Israel $0.029B 0.00
Tempest Therapeutics (TPST) United States $0.025B 0.00
CASI Pharmaceuticals (CASI) China $0.023B 0.00
Enlivex Therapeutics (ENLV) Israel $0.023B 0.00
Natural Alternatives (NAII) United States $0.020B 0.00
DURECT (DRRX) United States $0.020B 0.00
BioVie (BIVI) United States $0.020B 0.00
Lipocine (LPCN) United States $0.019B 0.00
Jupiter Neurosciences (JUNS) United States $0.019B 0.00
VYNE Therapeutics (VYNE) United States $0.019B 0.00
Mannatech (MTEX) United States $0.017B 0.00
TherapeuticsMD (TXMD) United States $0.017B 0.00
Relmada Therapeutics (RLMD) United States $0.017B 0.00
GlycoMimetics (GLYC) United States $0.017B 0.00
Ernexa Therapeutics (ERNA) United States $0.014B 0.00
MEI Pharma (MEIP) United States $0.014B 0.00
Vivos Therapeutics (VVOS) United States $0.014B 0.00
ProPhase Labs (PRPH) United States $0.013B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.013B 0.00
Scienture Holdings (SCNX) United States $0.012B 0.00
Cosmos Health (COSM) United States $0.012B 0.00
BioLineRx (BLRX) Israel $0.011B 0.00
Talphera (TLPH) United States $0.010B 0.00
Minerva Neurosciences (NERV) United States $0.010B 1.77
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Phio Pharmaceuticals (PHIO) United States $0.009B 0.00
Ainos (AIMD) United States $0.008B 0.00
Carisma Therapeutics (CARM) United States $0.008B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Citius Pharmaceuticals (CTXR) United States $0.008B 0.00
Klotho Neurosciences (KLTO) United States $0.008B 0.00
Traws Pharma (TRAW) United States $0.007B 0.00
Lyra Therapeutics (LYRA) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.006B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Plus Therapeutics (PSTV) United States $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
Conduit Pharmaceuticals (CDT) United States $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
Incannex Healthcare (IXHL) Australia $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.001B 0.00
SHINECO (SISI) China $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Petros Pharmaceuticals (PTPI) United States $0.000B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Aditxt (ADTX) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00